IVF with PGT-M in Mexico: Cost & What It Screens For

What PGT-M Is — and How It Differs from PGT-A

Preimplantation genetic testing comes in flavors that sound alike and do very different jobs, so let's separate them cleanly:

• PGT-A (aneuploidy) counts chromosomes. It screens embryos for the wrong number of chromosomes — the errors behind most miscarriages and conditions like Down syndrome. It tests for random errors, not inherited ones, and it's the common add-on you see priced at $2,000–$3,500 in Mexican IVF quotes.
• PGT-M (monogenic) looks for one specific inherited disease-causing mutation that you already know runs in your family — cystic fibrosis, Huntington's disease, sickle cell, BRCA, and hundreds of others. It's a custom-built test, designed around your family's exact mutation, that lets you transfer only unaffected embryos.
• PGT-SR (structural rearrangements) serves carriers of balanced translocations and similar chromosome rearrangements — a related but distinct test your clinic may also offer.

The practical distinction: PGT-A is a general quality screen almost anyone can add; PGT-M is precision medicine for families with a known genetic diagnosis. If you or your partner carry an identified mutation — or you've had carrier screening come back positive for the same recessive condition — PGT-M is the tool that changes your odds from a genetic coin flip to a selected, unaffected embryo.

PGT-M requires IVF by definition: embryos must exist in a lab to be biopsied. There is no PGT-M with IUI or natural conception.

What PGT-M Can Screen For

PGT-M can target essentially any condition caused by a known mutation in a single gene, once that mutation has been identified in your family. The categories:

• Autosomal recessive conditions — where both parents are carriers and each pregnancy has a 25% chance of an affected child: cystic fibrosis, sickle cell disease, spinal muscular atrophy (SMA), Tay-Sachs, beta-thalassemia, and most conditions flagged by expanded carrier screening panels.
• Autosomal dominant conditions — where one affected or carrier parent means a 50% risk per pregnancy: Huntington's disease, Marfan syndrome, myotonic dystrophy, familial adenomatous polyposis, and hereditary cancer syndromes including BRCA1/BRCA2 and Lynch syndrome.
• X-linked conditions — Duchenne muscular dystrophy, fragile X syndrome, hemophilia A and B, and others carried on the X chromosome.
• HLA matching — a specialized use where embryos are selected to be both unaffected and an immunological match for an existing sick child needing a stem cell transplant. Only a subset of labs handle these cases; ask directly.

Two prerequisites determine whether PGT-M is possible for you: the family mutation must be identified at the DNA level (a clinical diagnosis alone isn't enough — you need the genetic report naming the variant), and in most cases the lab needs DNA samples from relevant family members to build the test. If your family knows the disease but no one has been sequenced, that testing comes first.

How Much Does IVF with PGT-M Cost in Mexico?

Approximate 2026 ranges. PGT-M pricing has more moving parts than any other IVF add-on, so treat these as planning figures and demand itemized quotes.

Item	Mexico (USD)	Typical US (USD)
IVF cycle with ICSI (no meds)	$4,000–$7,500	$14,000–$22,000
Medications	$1,500–$3,500	$4,000–$7,000
PGT-M probe/test development (one-time)	$1,500–$3,500	$2,500–$6,000
PGT-M biopsy & analysis (per batch)	$2,500–$4,500	$5,000–$9,000
PGT-A added alongside (common)	$1,000–$2,000	$2,000–$4,000
Frozen embryo transfer	$1,500–$3,000	$3,500–$5,500
Realistic all-in pathway	$11,000–$19,000	$30,000–$48,000

Notes on how PGT-M pricing behaves:

• The probe fee is one-time; the analysis fee repeats. If you need a second retrieval to get more embryos, you pay biopsy and analysis again — but not probe development. Confirm this in writing.
• Many programs bundle PGT-A with PGT-M at a reduced combined rate, since the biopsy is taken once and both analyses run on it. Usually worth it: an embryo free of your family's mutation but chromosomally abnormal still won't make a healthy pregnancy.
• Where the analysis physically happens matters for price and timeline. Some Mexican labs run PGT-M in-house; others biopsy in Mexico and ship samples to reference labs in the US or Europe. Both models are legitimate — but shipping adds 1–3 weeks and sometimes cost, so ask which applies.
• Savings vs the US run 50–65% on the total pathway — proportionally similar to standard IVF, on a much larger bill.

For payment mechanics, see how to pay for IVF in Mexico.

How the Process Works, Step by Step

PGT-M stretches the standard IVF timeline at the front end. Here's the international-patient flow:

1. Genetic Consultation & Records (Weeks 0–4)

The clinic's genetics team reviews the family's genetic reports and confirms the exact variant. If the mutation hasn't been formally identified, sequencing for you (and possibly relatives) comes first — sometimes done at home, sometimes in Mexico.

2. Probe Development (4–10 weeks, before any stimulation)

The lab builds a custom test for your family's mutation, usually requiring cheek-swab or blood DNA from you, your partner, and often one or two relatives. This is the step that surprises everyone: nothing else can start until the probe is validated. Plan it into your calendar from day one.

3. IVF Cycle (standard timeline)

Once the probe is ready, the cycle proceeds exactly like conventional IVF — stimulation with remote monitoring at home, then a 3–5 day trip to Mexico for retrieval. Our remote monitoring guide covers the at-home portion. ICSI is standard for PGT-M cycles to keep stray sperm DNA from contaminating the test.

4. Culture, Biopsy & Analysis (1–4 weeks)

Embryos grow to Day 5 blastocysts; a few cells are biopsied from each and analyzed against your probe while the embryos are frozen. Results classify each embryo as unaffected, carrier (for recessive conditions), or affected.

5. Transfer Trip (2–4 days in Mexico)

A monitored preparation cycle at home, then the standard frozen transfer of a selected unaffected embryo.

Total elapsed time from first consult to transfer: typically 4–7 months — the probe is the difference from standard IVF's 2–4.

The Probe: The Step Nobody Warns You About

Because probe development shapes the whole experience, it deserves its own section:

• It takes 4–10 weeks and cannot be rushed or skipped. Patients who discover this after paying for a cycle end up with eggs retrieved and frozen while the probe catches up — workable, but not what anyone planned.
• It needs family DNA. For most conditions, samples from parents or affected relatives are required to distinguish the mutated copy of the gene from the healthy one. If key relatives are deceased or estranged, tell the lab early — workarounds exist for many cases but take longer.
• It's the fee to scrutinize. Confirm in writing: the probe price, whether it covers re-analysis for future cycles, and whether the probe remains usable if you return years later for a sibling. The right answers are "one-time," "yes," and "yes."

What PGT-M Can't Do

Honest expectations prevent expensive disappointment:

• It doesn't create embryos — it sorts them. If a cycle yields three blastocysts and two carry the mutation, you have one usable embryo. Families facing 50% dominant-condition odds should budget for the possibility of multiple retrievals; this is also why pairing PGT-M with a strong stimulation (rather than mini IVF) is usually advised.
• It tests for your family's condition, not everything. An embryo can be unaffected by your mutation and still face any of the ordinary risks of pregnancy. Adding PGT-A covers chromosome count; nothing covers everything.
• Accuracy is high but not absolute. Misdiagnosis rates are well under 1–2% at good labs, but prenatal confirmation testing (CVS or amniocentesis) is still recommended in pregnancy — a good clinic says this unprompted.
• A biopsy result reflects a few cells. Rare mosaic results and "no-result" embryos happen; ask the lab how they handle and report them.

How to Vet a Clinic and Lab for PGT-M

The standard five-point test applies — COFEPRIS license, REDLARA membership, a direct English video call with the physician, a written remote-monitoring protocol, and an itemized quote (see Is IVF in Mexico Safe?). For PGT-M, add four questions:

1. "Who performs the genetic analysis, and what accreditation does that lab hold?" Whether in-house or a US/European reference lab, you want a named laboratory with recognized accreditation (CAP/CLIA or ISO 15189) — not a vague "our genetics partner."
2. "How many PGT-M cases — not PGT-A — has your program completed, and any for my condition?" PGT-M volume is a fraction of PGT-A volume everywhere; experience with monogenic cases specifically is what you're buying.
3. "Who does the biopsies, and what's your embryo survival rate post-biopsy?" Should be their own embryologists, with survival above 95%.
4. "Do you provide genetic counseling in English, before and after results?" PGT-M decisions — especially around carrier embryos and adult-onset conditions like BRCA — deserve a counselor, not a price sheet.